Rationale, design and objectives of ARegPKD, a European ARPKD registry study.
Ebner K, Feldkoetter M, Ariceta G, Bergmann C, Buettner R, Doyon A, Duzova A, Goebel H, Haffner D, Hero B, Hoppe B, Illig T, Jankauskiene A, Klopp N, König J, Litwin M, Mekahli D, Ranchin B, Sander A, Testa S, Weber LT, Wicher D, Yuzbasioglu A, Zerres K, Dötsch J, Schaefer F, Liebau MC; ESCAPE Study Group; GPN Study Group.
Ebner K, et al. Among authors: klopp n.
BMC Nephrol. 2015 Feb 18;16:22. doi: 10.1186/s12882-015-0002-z.
BMC Nephrol. 2015.
PMID: 25886171
Free PMC article.
The underlying pathophysiology, the mechanisms resulting in the observed clinical heterogeneity and the long-term clinical evolution of patients remain poorly understood. Current treatment approaches continue to be largely symptomatic and opinion-based even in most-advance …
The underlying pathophysiology, the mechanisms resulting in the observed clinical heterogeneity and the long-term clinical evolution …